BackSatellos Bioscience Common Stock Overview
Satellos Bioscience Inc. Common Stock

Satellos Bioscience Common Stock Return on Equity

Satellos Bioscience Common Stock (MSLE) has a ROE of -57.12%, below the sector sector average of -5.68%.

Get informed when a big investor buys or sells

+ Follow

ROE

-57.12%

Return on Equity

-57.12%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Satellos Bioscience Common Stock (MSLE) FAQ

Satellos Bioscience Common Stock (MSLE) currently reports a ROE of -57.12%. That is below the sector sector average of -5.68%. Use the charts on this page to explore Satellos Bioscience Common Stock's ROE history and peer comparisons.

Satellos Bioscience Common Stock's ROE of -57.12% is lower than the its sector sector average of -5.68%. That is roughly 905.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Satellos Bioscience Common Stock's current -57.12% should be judged against industry norms (sector average: -5.68%) and against MSLE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -57.12%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Satellos Bioscience Common Stock, and consider following MSLE for alerts when major investors trade the stock.